Atlas Trials

A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL

Clinical trial NCT05054465 · UNKNOWN

Trial details

NCT number
NCT05054465
Sponsor
Israeli Medical Association
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2021-10-01
Primary completion
2025-08-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.